News
CPT codes for OGM are key components for obtaining reimbursement from third party payers when labs use LDTs based on OGM as alternatives to legacy cytogenetics methods such as karyotyping, ...
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics (BNGO), announced that Centers for Medicare & Medicaid Services, CMS, posted ...
LONDON, GREATER LONDON, UNITED KINGDOM, September 15, 2025 /EINPresswire.com/ -- How Much Is The Somatic Genetic Testing Market Worth? The market size for somatic genetic testing has seen brisk growth ...
In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...
LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 /EINPresswire.com/ -- Genetic Analysis Market Growth Forecast: What To Expect By 2025? The market size for genetic analysis has seen a swift ...
A New York judge has allowed DNA evidence obtained through advanced techniques into the forthcoming murder trial of the man ...
Functional genomics, which is seeing how genetic variants behave in biological systems through genetic testing, is offering new hope for African cancer patients.
Genetic testing of IVF-created embryos could help more women over 35 have a baby in less time, a clinical trial by researchers from King's College London, King's College Hospital, and King's Fertility ...
Insurance covers some genetic tests, such as BRCA tests for breast cancer, if you meet certain requirements. Find Cheap Health Insurance Quotes in Your Area But there are about 70,000 different ...
A genetic test could predict whether a child will be obese as an adult. A global study, published in the journal Nature Medicine, found that the risk of severe obesity in adulthood can be identified ...
Several businesses and nonprofits have recently opened or will soon open medical-related facilities in south-central Pennsylvania. Our list below includes behavioral services offices, a genetic ...
A prospective trial of gastrointestinal cancer patients showed the feasibility of preemptive genetic testing for DPYD/UGT1A1 variants associated with increased chemotherapy toxicity. Genotype-guided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results